Cargando…
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
Diabetes is a condition that affects a large percentage of the population and it is the leading cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in mortality and when compared to non-diabetics, the intensity and prevalence of COVID-19 ailment among diabetic...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080053/ https://www.ncbi.nlm.nih.gov/pubmed/35569351 http://dx.doi.org/10.1016/j.biopha.2022.113089 |
_version_ | 1784702697262284800 |
---|---|
author | Sharma, Prateek Behl, Tapan Sharma, Neelam Singh, Sukhbir Grewal, Ajmer Singh Albarrati, Ali Albratty, Mohammed Meraya, Abdulkarim M. Bungau, Simona |
author_facet | Sharma, Prateek Behl, Tapan Sharma, Neelam Singh, Sukhbir Grewal, Ajmer Singh Albarrati, Ali Albratty, Mohammed Meraya, Abdulkarim M. Bungau, Simona |
author_sort | Sharma, Prateek |
collection | PubMed |
description | Diabetes is a condition that affects a large percentage of the population and it is the leading cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in mortality and when compared to non-diabetics, the intensity and prevalence of COVID-19 ailment among diabetic individuals are more. Since its discovery in Wuhan, COVID-19 has grown rapidly and shown a wide range of severity. Temperature, lymphopenia, non-productive cough, dyspnoea, and tiredness are recognized as the characteristic of individuals infected with COVID-19 disease. In COVID-19 patients, diabetes and other related comorbidities are substantial predictors of disease and mortality. According to a recent study, SARS-CoV-2 (the virus responsible for covid-19 disease) may also lead to direct pancreatic harm, which could aggravate hyperglycemia and potentially cause the establishment of diabetes in formerly non-diabetic individuals. This bidirectional association of COVID-19 and diabetes load the burden on health care professionals throughout the world. It is recommended that gliptin medications be taken moderately, blood glucose levels must be kept under control, ACE inhibitors should be used in moderation, decrease the number of avoidable hospitalizations, nutritional considerations, and some other prevention measures, such as immunization, are highly recommended. SARS-CoV-2 may cause pleiotropic changes in glucose homeostasis, which could exacerbate the pathophysiology of pre-existing diabetes or result in new disease processes. |
format | Online Article Text |
id | pubmed-9080053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90800532022-05-09 COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality Sharma, Prateek Behl, Tapan Sharma, Neelam Singh, Sukhbir Grewal, Ajmer Singh Albarrati, Ali Albratty, Mohammed Meraya, Abdulkarim M. Bungau, Simona Biomed Pharmacother Review Diabetes is a condition that affects a large percentage of the population and it is the leading cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in mortality and when compared to non-diabetics, the intensity and prevalence of COVID-19 ailment among diabetic individuals are more. Since its discovery in Wuhan, COVID-19 has grown rapidly and shown a wide range of severity. Temperature, lymphopenia, non-productive cough, dyspnoea, and tiredness are recognized as the characteristic of individuals infected with COVID-19 disease. In COVID-19 patients, diabetes and other related comorbidities are substantial predictors of disease and mortality. According to a recent study, SARS-CoV-2 (the virus responsible for covid-19 disease) may also lead to direct pancreatic harm, which could aggravate hyperglycemia and potentially cause the establishment of diabetes in formerly non-diabetic individuals. This bidirectional association of COVID-19 and diabetes load the burden on health care professionals throughout the world. It is recommended that gliptin medications be taken moderately, blood glucose levels must be kept under control, ACE inhibitors should be used in moderation, decrease the number of avoidable hospitalizations, nutritional considerations, and some other prevention measures, such as immunization, are highly recommended. SARS-CoV-2 may cause pleiotropic changes in glucose homeostasis, which could exacerbate the pathophysiology of pre-existing diabetes or result in new disease processes. The Author(s). Published by Elsevier Masson SAS. 2022-07 2022-05-08 /pmc/articles/PMC9080053/ /pubmed/35569351 http://dx.doi.org/10.1016/j.biopha.2022.113089 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Sharma, Prateek Behl, Tapan Sharma, Neelam Singh, Sukhbir Grewal, Ajmer Singh Albarrati, Ali Albratty, Mohammed Meraya, Abdulkarim M. Bungau, Simona COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title | COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title_full | COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title_fullStr | COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title_full_unstemmed | COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title_short | COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality |
title_sort | covid-19 and diabetes: association intensify risk factors for morbidity and mortality |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080053/ https://www.ncbi.nlm.nih.gov/pubmed/35569351 http://dx.doi.org/10.1016/j.biopha.2022.113089 |
work_keys_str_mv | AT sharmaprateek covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT behltapan covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT sharmaneelam covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT singhsukhbir covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT grewalajmersingh covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT albarratiali covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT albrattymohammed covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT merayaabdulkarimm covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality AT bungausimona covid19anddiabetesassociationintensifyriskfactorsformorbidityandmortality |